Inner ear MRI enhancement based on three dimensional-real IR sequence in patients with Meniere's disease after intravenous gadolinium injection: Comparison of different doses used and exploration of an appropriate dose.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101247023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-4486 (Electronic) Linking ISSN: 17494478 NLM ISO Abbreviation: Clin Otolaryngol Subsets: MEDLINE

Original Publication: Oxford : Blackwell Scientific Publications, c2005-

Ear, Inner*/diagnostic imaging ; Meniere Disease*/diagnostic imaging; Contrast Media ; Gadolinium ; Gadolinium DTPA ; Humans ; Injections, Intravenous ; Magnetic Resonance Imaging/methods ; Prospective Studies

Objectives: Three-dimensional inversion-recovery sequence with real reconstruction (3D-real IR) magnetic resonance imaging (MRI) can detect endolymphatic hydrops of the inner ear. We aimed to explore a appropriate dose for intravenous gadolinium injection.
Design: Observational prospective study.
Setting: Tertiary referral centre.
Participants: We collected 90 unilateral definite Meniere's disease patients.
Main Outcome Measures: All enrolled patients were divided into three groups randomly (patients in group A, B and C received gadolinium injection in 1/1.5/2 times doses respectively). After 4 h, inner ear MRI scans were applied.
Results: The signal intensities of B-affected ears and C-affected ears were significantly higher than A-affected ears (p < .05); however, no difference was found between B-affected ears and C-affected ears (p = .267). The same conditions also appeared in the three unaffected-ear groups. Moreover, the signal intensities of affected-ear in group A, B and C were significantly higher than that of the corresponding unaffected-ear groups (p < .05). Besides, the subjective visual evaluation scores of group B and C were significantly better than that of group A (p < .05).
Conclusions: Intravenous injection of gadolinium in a single dose may be unbefitting for the inner ear imaging based on 3D-real IR MRI, both the applications of gadolinium in 1.5 times and double doses can have a good perilymphatic enhancement effect of inner ear. In order to minimise the use of dose for avoiding or mitigating the adverse reactions and renal damage, 1.5 times dose may be preferred in clinical practice.
(© 2022 John Wiley & Sons Ltd.)

Hallpike CS, Cairns H. Observations on the pathology of Ménière's syndrome: (Section of Otology). Proc R Soc Med. 1938;31:1317-1336.
Tanioka H, Zusho H, Machida T, Sasaki Y, Shirakawa T. High-resolution MR imaging of the inner ear: findings in Menière's disease. Eur J Radiol. 1992;15:83-88.
Naganawa S, Yamakawa K, Fukatsu H, et al. High-resolution T2-weighted MR imaging of the inner ear using a long echo-train-length 3D fast spin-echo sequence. Eur Radiol. 1996;6:369-374.
Tanioka H, Kaga H, Zusho H, Araki T, Sasaki Y. MR of the endolymphatic duct and sac: findings in Menière disease. AJNR Am J Neuroradiol. 1997;18:45-51.
Lorenzi MC, Bento RF, Daniel MM, Leite CC. Magnetic resonance imaging of the temporal bone in patients with Ménière's disease. Acta Otolaryngol. 2000;120:615-619.
Salt AN, Henson MM, Gewalt SL, Keating AW, DeMott JE, Henson OW Jr. Detection and quantification of endolymphatic hydrops in the guinea pig cochlea by magnetic resonance microscopy. Hear Res. 1995;88:79-86.
Niyazov DM, Andrews JC, Strelioff D, Sinha S, Lufkin R. Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging. Otol Neurotol. 2001;22:813-817.
Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope. 2007;117:415-420.
Zhao M, Liu Z, Sha Y, et al. Visualization of endolymphatic hydrops after intratympanic injection of Gd-DTPA: a comparison of high resolution three dimensional-real inversion recovery and three dimensional fluid-attenuated inversion recovery with a variable flip angle sequence. Chin J Radiol. 2016;50:581-585.
Suárez Vega VM, Dominguez P, Caballeros Lam FM, Leal JI, Perez-Fernandez N. Comparison between high-resolution 3D-IR with real reconstruction and 3D-flair sequences in the assessment of endolymphatic hydrops in 3 tesla. Acta Otolaryngol. 2020;140:883-888.
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci. 2010;9:237-242.
Suzuki H, Teranishi M, Sone M, Yamazaki M, Naganawa S, Nakashima T. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Acta Otolaryngol. 2011;131:1025-1031.
Naganawa S, Ito R, Kato Y, et al. Intracranial distribution of intravenously administered gadolinium-based contrast agent over a period of 24 hours: evaluation with 3D-real IR imaging and MR fingerprinting. Magn Reson Med Sci. 2021;20:91-98.
Li Y, Sha Y, Wang F, et al. Comprehensive comparison of MR image quality between intratympanic and intravenous gadolinium injection using 3D real IR sequences. Acta Otolaryngol. 2019;139:659-664.
Chen W, Geng Y, Luo S, Lin N, Sha Y. The correlation of clinical features and endolymphatic hydrops visualized by 3D-real IR MRI in children with sudden sensorineural hearing loss. Ear Nose Throat J. 2021;13:1455613211009432.
Goebel JA. 2015 Equilibrium Committee Amendment to the 1995 AAO-HNS guidelines for the definition of Ménière's disease. Otolaryngol Head Neck Surg. 2016;154:403-404.
Shi S, Guo P, Wang W. Magnetic resonance imaging of Meniere's disease after intravenous administration of gadolinium. Ann Otol Rhinol Laryngol. 2018;127:777-782.
Shi S, Sun W, Wang W. Clinical features and imaging characteristics of Meniere's disease verified by intravenous gadolinium contrast-enhanced magnetic resonance imaging. Zhonghua Yi Xue Za Zhi. 2018;98:1218-1222.
Attyé A, Eliezer M, Boudiaf N, et al. MRI of endolymphatic hydrops in patients with Meniere's disease: a case-controlled study with a simplified classification based on saccular morphology. Eur Radiol. 2017;27:3138-3146.
Attyé A, Dumas G, Troprès I, et al. Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice? Eur Radiol. 2015;25:3043-3049.
Teranishi M, Naganawa S, Katayama N, et al. Image evaluation of endolymphatic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol. 2009;266:1871-1877.
Naganawa S, Sugiura M, Kawamura M, Fukatsu H, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylene-triamine pentaacetic acid. AJNR Am J Neuroradiol. 2008;29:724-726.
Naganawa S, Nakashima T. Cutting edge of inner ear MRI. Acta Otolaryngol Suppl. 2009;560:15-21.
Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol. 2008;18:920-924.
Tagaya M, Yamazaki M, Teranishi M, et al. Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease. Acta Otolaryngol. 2011;131:474-479.

Keywords: Meniere's disease; dose; gadolinium; magnetic resonance imaging; reconstruction

0 (Contrast Media)
AU0V1LM3JT (Gadolinium)
K2I13DR72L (Gadolinium DTPA)

Date Created: 20220116 Date Completed: 20221011 Latest Revision: 20221206

20240829

10.1111/coa.13912

35034431